Hyperglycaemia distorts the insulin/insulin receptor/phosphatidylinositol 3 kinases/GLUT signalling pathway, which results in hyperinsulinaemia and the activation of many inflammatory factors, such as cytokines and adhesion factors. The gene discussed is SLC2A1; the disease is Hyperglycemia.